Search for Clinical Trial Results

Sponsored By

Paranasal Sinus Neoplasms - 3 Studies Found

Status Study
Completed Study Name: Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer
Condition:
  • Cancer of the Pharynx
  • Cancer of the Larynx
  • Cancer of the N
    Date: 2009-09-01
    Interventions: Drug: erlotinib + celecoxib In this phase I/II study, patients will be treated with daily erlotinib 150
Completed Study Name: Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)
Condition:
  • Cancer of the Pharynx
  • Cancer of the Larynx
  • Cancer of the N
    Date: 2005-06-30
    Interventions:
    • Drug: docetaxel 75 mg/m2 on da
Withdrawn Study Name: S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer
Condition:
  • Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity
  • Recurrent Squamous Cell Carcino
    Date: 2004-11-05
    Interventions:
    • Drug: capecitabine
    • Procedure: adjuvant the